Red blood cell–hitchhiking fluorescent probe to promote intraoperative diagnosis of human ovarian tumor
Science Advances · 05.12.2025 · 11 (49)
DOI: 10.1126/sciadv.aea6618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 05.12.2025. Verfasst von Yijing Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Fluorescent Dyes, Erythrocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Shanghai, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Ovarian cancer is the deadliest gynecological malignancy. The fluorescence-guided surgery technique provides a real-time visualization of the desired regions to guide the tumor resection. However, the fluorescent probes used in clinics suffer from the limited selectivity of ovarian tumors and short blood circulation half-lives. Here, we design an activatable trident-like fluorescent peptide probe (RMN) to bind with the ovarian tumor-overexpressed N-cadherin and respond to the matrix metalloproteinases (MMPs). Upon intravenous administration, the RMN initially hitchhikes on the red blood cell (RBC) surface with prolonged circulation half-lives. When arriving at the tumor regions, the peptide sequence is cleaved by the tumor-secreted MMPs to recover the fluorescent signals. The released “spears” containing N-cadherin–targeting moiety and fluorophore can specifically recognize the ovarian tumor cells, thereby facilitating the visualization of primary or metastatic tumor regions. Overall, this study highlights the potential of RBC-hitchhiking fluorescent probes in advancing the intraoperative diagnosis of human ovarian tumor tissues during the fluorescence-guided surgery process in clinics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Department of Bioengineering, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.
- School of Design, Shanghai Jiao Tong University, Shanghai 200240, China.
- Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310003, China.
- Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
ORCID-Profile: Yijing Lin, Ke Li, Seok Theng Chiang, Haonan Wang, Xiangzhao Ai, Weiwei Feng
Förderung
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Lin, Y., Li, K., Ding, Y., Chiang, S. T., Xia, J., Wang, H., Wang, H., Ai, X., & Feng, W. (2025). Red blood cell–hitchhiking fluorescent probe to promote intraoperative diagnosis of human ovarian tumor. Science Advances, 11(49). https://doi.org/10.1126/sciadv.aea6618
Vancouver
Lin Y, Li K, Ding Y, Chiang ST, Xia J, Wang H, et al. Red blood cell–hitchhiking fluorescent probe to promote intraoperative diagnosis of human ovarian tumor. Science Advances. 2025;11(49). doi:10.1126/sciadv.aea6618
BibTeX
@article{Lin2025,
author = {Lin, Yijing and Li, Ke and Ding, Yue and Chiang, Seok Theng and Xia, Jingzhou and Wang, Haonan and Wang, Huafeng and Ai, Xiangzhao and Feng, Weiwei},
title = {Red blood cell–hitchhiking fluorescent probe to promote intraoperative diagnosis of human ovarian tumor},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {49},
doi = {10.1126/sciadv.aea6618}
}
EUVIMED